Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by bull8888on Mar 15, 2007 4:21pm
894 Views
Post# 12426196

RE: Kill the shorters

RE: Kill the shortersLarge posted: "We are playing a game. Set you limit sell orders on RVX between $52.88-$53.09 and set the date to April 12. That way the broker can't short your shares." In general, this is often a good idea. But be careful with this stock. If you believe/hope/expect the buyout to be north of $50, and you either don't monitor the markets on a regular basis/are going on a holiday, etc., you might want to be careful. We have no idea what the final buyout price is going to be, and we also don't know how much of a premium will be built into the buyout. Say for example if the buyout is $100 Cdn, we may see a rapid increase in SP prior to the actual news, in which the SP may go from $25 to say $70 quite rapidly. Or it may sit at well below FMV and then have a larger premium built into the buyout. All I'm saying is be careful with this strategy if you are hopeful of a buyout in excess of $50. Don't want to get caught selling your shares before you really want to.
Bullboard Posts